CLINICAL_TRIALS
trial_result
· 2021-06-10
Clinical Trial Update: Troxacitabine in Treating Patients With Chronic Myelogenous Leukemia [Phase 2]
Summary
Phase 2 clinical trial update evaluating troxacitabine in patients with leukemia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shire | Conditions: Leukemia | Phase 2 | Status: COMPLETED